Market Tracker

06/24 5:16pm ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

3.16
Delayed Data
As of 4:00pm ET
 +0.25 / +8.59%
Today’s Change
1.13
Today|||52-Week Range
4.37
-3.66%
Year-to-Date

Today’s Trading

Previous close2.91
Today’s open2.78
Day’s range2.66 - 3.23
Volume567,622
Average volume (3 months)120,259
Market cap$130.3M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-269.23%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-6.38%
P/E ratioNM
Price/Sales44.43
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MSLIMerus Labs Internati...-0.06-4.85%
EIGREiger BioPharmaceuti...-0.89-4.74%
LPCNLipocine Inc-0.31-4.31%
CRBPCorbus Pharmaceutica...-0.02-0.66%
Data as of 4:00pm ET, 06/24/2016

Financials

Last reporting dateMarch 11, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$2.8M
Annual profit (last year)-$17.9M
Net profit margin-647.67%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer &
Secretary
Erik Danielsen
Corporate headquarters
Saint-Laurent, Quă©bec

Forecasts